WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007093747) USE OF TESAGLITIZAR FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/093747    International Application No.:    PCT/FR2007/050809
Publication Date: 23.08.2007 International Filing Date: 15.02.2007
IPC:
A61K 31/192 (2006.01), A61P 17/00 (2006.01), A61P 17/08 (2006.01), A61P 17/10 (2006.01)
Applicants: GALDERMA RESEARCH & DEVELOPMENT [FR/FR]; 2400 Route des Colles, Les Templiers, F-06410 Biot (FR) (For All Designated States Except US).
BOITEAU, Jean-Guy [FR/FR]; (FR) (For US Only).
CLARY, Laurence [FR/FR]; (FR) (For US Only).
RIVIER, Michel [FR/FR]; (FR) (For US Only)
Inventors: BOITEAU, Jean-Guy; (FR).
CLARY, Laurence; (FR).
RIVIER, Michel; (FR)
Agent: ANDRAL, Christophe; L'OREAL, River Plaza, D.I.P.I., F-92665 Asnieres-sur-Seine Cedex (FR)
Priority Data:
0601406 17.02.2006 FR
Title (EN) USE OF TESAGLITIZAR FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISORDERS
(FR) UTILISATION DU TESAGLITAZAR POUR LA PREPARATION D'UNE COMPOSITION PHARMACEUTIQUE DESTINEE AU TRAITEMENT DES AFFECTIONS DERMATOLOGIQUES
Abstract: front page image
(EN)The invention relates to the use of at least one compound selected from 2-ethoxy-3-[4-[2-[4-[ (methylsulfonyl)oxy]phenyl]ethoxy]phenyl propanoic acid, the isomers thereof, especially optical, and/or the pharmaceutical salts thereof, for preparing a pharamceutical composition for the treatment of skin disorders.
(FR)L'invention se rapporte à l'utilisation d'au moins un composé choisi parmi l'acide 2-éthoxy-3-[4-[2-[4-[ (méthylsulfonyl)oxy]phényl]éthoxy]phénylpropanoïque, ses isomères, notamment optiques, et/ou ses sels pharmaceutiquement acceptables, pour la préparation d'une composition pharmaceutique destinée à traiter des affections dermatologiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)